• Magazine
  • ENEWS
  • SUBSCRIBE
  • WEBINARS
  • PODCASTS
  • EBOOKS
    1. Home

    J&J restructuring to integrate R&D, marketing, ops

    May 8, 2006
    Last Friday, the New York Times reported that J&J has restructured, organizing its operations along three major categories of therapies:
    • treatments for pain, inflectious diseases, CNS, metabolic and cardiovascular diseases
    • immune-related
    • virology-related.
    Overseeing all R&D, commercial and operations activites for the company's pharmaceuticals group will be Joseph Scodari.
    Last Friday, the New York Timesreported that J&J has restructured, organizing its operations along three major categories of therapies:
    • treatments for pain, inflectious diseases, CNS, metabolic and cardiovascular diseases
    • immune-related
    • virology-related.
    Overseeing all R&D, commercial and operations activites for the company's pharmaceuticals group will be Joseph Scodari.

    About the Author

    pharmamanufacturing | pharmamanufacturing